Photodynamic Therapy for Oral Precursor Lesions
Launched by MEDICAL UNIVERSITY OF VIENNA · Dec 22, 2011
Trial Information
Current as of June 04, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Existing Leukoplakia simplex SIN III (diagnostics by Biopsie)
- • Leukoplakia verrucosa without indications of malignant changes (diagnostics by Biopsie)
- • Oral Lichen planus SIN III (diagnostics by Biopsie)
- • Good mouth hygiene status (tartar, surface)
- • Correct seat of the prosthesis and/or the denture
- • Located erosions in the oral cavity
- • Minimum age:18 years
- • Women at the age capable of child-bearing with an appropriate contraception
- Exclusion Criteria:
- • Malignant changes of the mucous membrane, heavy Dysplasie SIN III, Carcinoma in situ - heavy vitamin deficiency
- • Pregnancy
- • less than 18
- • Satisfying women
- • No tobacco abuse
- • satisfying therapy with local immunmodulators in lichen ruber
- • surgical therapy of leukoplakia indicated
About Medical University Of Vienna
The Medical University of Vienna is a leading research institution dedicated to advancing healthcare through innovative clinical research and education. Renowned for its commitment to excellence in medical science, the university fosters interdisciplinary collaboration among researchers, clinicians, and academic professionals. Its clinical trials encompass a wide range of medical disciplines, aiming to develop cutting-edge therapies and improve patient outcomes. With state-of-the-art facilities and a strong emphasis on ethical standards, the Medical University of Vienna is at the forefront of transforming scientific discoveries into practical applications that enhance global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vienna, , Austria
Patients applied
Trial Officials
Gabriella Dvorak, PD, DMD, MD
Study Director
Medical University Vienna
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials